Role of γδ T cells in West Nile virus-induced encephalitis: Friend or foe?

Journal of Neuroimmunology

Volumn 240-241, Issue , 2011, Pages 22-27

  Wang, Tian ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Encephalitis; Gamma delta T cells; West Nile virus

Indexed keywords

T LYMPHOCYTE RECEPTOR;

CELL MATURATION; DENDRITIC CELL; DISEASE MODEL; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS ENCEPHALITIS; WEST NILE FLAVIVIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 83555177251     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.10.004     Document Type: Review

References (77)

1. Alpert S.G., Fergerson J., Noel L.P. Intrauterine West Nile virus: ocular and systemic findings. Am. J. Ophthalmol. 2003, 136:733-735.
2. Anderson J.F., Rahal J.J. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg. Infect. Dis. 2002, 8:107-108.
3. Anon. Laboratory-acquired West Nile virus infections-United States. MMWR Morb. Mortal. Wkly. Rep. 2002, 51:1133-1135.
4. Anon. Possible West Nile virus transmission to an infant through breast-feeding-Michigan. MMWR Morb. Mortal. Wkly. Rep. 2002, 51:877-878.
5. Arjona A., Foellmer H.G., Town T., Leng L., McDonald C., Wang T., Wong S.J., Montgomery R.R., Fikrig E., Bucala R. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 2007, 117:3059-3066.
6. Bai F., Town T., Qian F., Wang P., Kamanaka M., Connolly T.M., Gate D., Montgomery R.R., Flavell R.A., Fikrig E. IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog. 2009, 5:e1000610.
7. Bank I., DePinho R.A., Brenner M.B., Cassimeris J., Alt F.W., Chess L. A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature 1986, 322:179-181.
8. Ben-Nathan D., Huitinga I., Lustig S., van Rooijen N., Kobiler D. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch. Virol. 1996, 141:459-469.
9. Brehin A.C., Mouries J., Frenkiel M.P., Dadaglio G., Despres P., Lafon M., Couderc T. Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population. J. Immunol. 2008, 180:6760-6767.
10. Byrne S.N., Halliday G.M., Johnston L.J., King N.J. Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J. Invest. Dermatol. 2001, 117:702-709.
11. Cai J.L., Tucker P.W. Gammadelta T cells: immunoregulatory functions and immunoprotection. Chem. Immunol. 2001, 79:99-138.
12. Campbell G.L., Marfin A.A., Lanciotti R.S., Gubler D.J. West Nile virus. Lancet Infect. Dis. 2002, 2:519-529.
13. Chang J., Braciale T.J. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat. Med. 2002, 8:54-60.
14. Charatan F. Organ transplants and blood transfusions may transmit West Nile virus. BMJ 2002, 325:566.
15. Collins C., Wolfe J., Roessner K., Shi C., Sigal L.H., Budd R.C. Lyme arthritis synovial gammadelta T cells instruct dendritic cells via fas ligand. J. Immunol. 2005, 175:5656-5665.
16. Daffis S., Samuel M.A., Suthar M.S., Gale M., Diamond M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 2008, 82:10349-10358.
17. Dalton J.E., Howell G., Pearson J., Scott P., Carding S.R. Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. J. Immunol. 2004, 173:3660-3667.
18. Davis B.S., Chang G.J., Cropp B., Roehrig J.T., Martin D.A., Mitchell C.J., Bowen R., Bunning M.L. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 2001, 75:4040-4047.
19. Diamond M.S., Shrestha B., Mehlhop E., Sitati E., Engle M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 2003, 16:259-278.
20. Diamond M.S., Sitati E.M., Friend L.D., Higgs S., Shrestha B., Engle M. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 2003, 198:1853-1862.
21. Dietrich J.B. The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J. Neuroimmunol. 2002, 128:58-68.
22. Eberl M., Engel R., Aberle S., Fisch P., Jomaa H., Pircher H. Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1). J. Leukoc. Biol. 2005, 77:67-70.
23. Fang H., Welte T., Zheng X., Chang G.J., Holbrook M.R., Soong L., Wang T. Gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol Med Microbiol 2010, 59:71-80.
24. Flierl M.A., Rittirsch D., Gao H., Hoesel L.M., Nadeau B.A., Day D.E., Zetoune F.S., Sarma J.V., Huber-Lang M.S., Ferrara J.L., Ward P.A. Adverse functions of IL-17A in experimental sepsis. FASEB J. 2008, 22:2198-2205.
25. Fredericksen B.L., Gale M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J. Virol. 2006, 80:2913-2923.
26. Fredericksen B.L., Keller B.C., Fornek J., Katze M.G., Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 2008, 82:609-616.
27. Girardi M. Immunosurveillance and immunoregulation by gammadelta T cells. J. Invest. Dermatol. 2006, 126:25-31.
28. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 2001, 19:65-91.
29. Hahn Y.S., Ji X.Y., Woo S.I., Choi Y.K., Song M.S., Shin K.S., Jin N., O'Brien R.L., Born W.K. Vgamma1+ gammadelta T cells reduce IL-10-producing CD4+CD25+ T cells in the lung of ovalbumin-sensitized and challenged mice. Immunol. Lett. 2008, 121:87-92.
30. Halevy M., Akov Y., Ben-Nathan D., Kobiler D., Lachmi B., Lustig S. Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch. Virol. 1994, 137:355-370.
31. Hayday A.C. Gammadelta cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 2000, 18:975-1026.
32. Huber S.A., Graveline D., Newell M.K., Born W.K., O'Brien R.L. V gamma 1+ T cells suppress and V gamma 4+ T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice. J. Immunol. 2000, 165:4174-4181.
33. Ismaili J., Olislagers V., Poupot R., Fournie J.J., Goldman M. Human gamma delta T cells induce dendritic cell maturation. Clin. Immunol. 2002, 103:296-302.
34. Johnston L.J., Halliday G.M., King N.J. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J. Invest. Dermatol. 2000, 114:560-568.
35. Katze M.G., He Y., Gale M. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2002, 2:675-687.
36. Kesson A.M., Blanden R.V., Mullbacher A. The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile. J. Gen. Virol. 1987, 68:2001-2006.
37. Kramer L.D., Bernard K.A. West Nile virus infection in birds and mammals. Ann. N. Y. Acad. Sci. 2001, 951:84-93.
38. Kramer L.D., Styer L.M., Ebel G.D. A global perspective on the epidemiology of West Nile virus. Annu. Rev. Entomol. 2008, 53:61-81.
39. Kulkarni A.B., Mullbacher A., Blanden R.V. Functional analysis of macrophages, B cells and splenic dendritic cells as antigen-presenting cells in West Nile virus-specific murine T lymphocyte proliferation. Immunol. Cell Biol. 1991, 69(Pt 2):71-80.
40. Kunzmann V., Kretzschmar E., Herrmann T., Wilhelm M. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons. Immunology 2004, 112:369-377.
41. Leslie D.S., Vincent M.S., Spada F.M., Das H., Sugita M., Morita C.T., Brenner M.B. CD1-mediated gamma/delta T cell maturation of dendritic cells. J. Exp. Med. 2002, 196:1575-1584.
42. Liu Y., Blanden R.V., Mullbacher A. Identification of cytolytic lymphocytes in West Nile virus-infected murine central nervous system. J. Gen. Virol. 1989, 70:565-573.
43. Lucas M., Mashimo T., Frenkiel M.P., Simon-Chazottes D., Montagutelli X., Ceccaldi P.E., Guenet J.L., Despres P. Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein. Immunol. Cell Biol. 2003, 81:230-236.
44. Munz C., Steinman R.M., Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 2005, 202:203-207.
45. Ninomiya T., Takimoto H., Matsuzaki G., Hamano S., Yoshida H., Yoshikai Y., Kimura G., Nomoto K. Vgamma1+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma. Immunology 2000, 99:187-194.
46. O'Brien R.L., Yin X., Huber S.A., Ikuta K., Born W.K. Depletion of a gamma delta T cell subset can increase host resistance to a bacterial infection. J. Immunol. 2000, 165:6472-6479.
47. Paessler S., Yun N.E., Judy B.M., Dziuba N., Zacks M.A., Grund A.H., Frolov I., Campbell G.A., Weaver S.C., Estes D.M. Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology 2007, 367:307-323.
48. Pletnev A.G., Swayne D.E., Speicher J., Rumyantsev A.A., Murphy B.R. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine 2006, 24:6392-6404.
49. Ponomarev E.D., Dittel B.N. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J. Immunol. 2005, 174:4678-4687.
50. Ponomarev E.D., Novikova M., Yassai M., Szczepanik M., Gorski J., Dittel B.N. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis. J. Immunol. 2004, 173:1587-1595.
51. Ratterree M.S., Gutierrez R.A., Travassos da Rosa A.P., Dille B.J., Beasley D.W., Bohm R.P., Desai S.M., Didier P.J., Bikenmeyer L.G., Dawson G.J., Leary T.P., Schochetman G., Phillippi-Falkenstein K., Arroyo J., Barrett A.D., Tesh R.B. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J. Infect. Dis. 2004, 189:669-676.
52. Roark C.L., French J.D., Taylor M.A., Bendele A.M., Born W.K., O'Brien R.L. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing {gamma}{delta T cells}. J. Immunol. 2007, 179:5576-5583.
53. Roehrig J.T., Staudinger L.A., Hunt A.R., Mathews J.H., Blair C.D. Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann. N. Y. Acad. Sci. 2001, 951:286-297.
54. Rowell J.F., Griffin D.E. Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis. J. Neuroimmunol. 2002, 127:106-114.
55. Sampson B.A., Armbrustmacher V. West Nile encephalitis: the neuropathology of four fatalities. Ann. N. Y. Acad. Sci. 2001, 951:172-178.
56. Samuel M.A., Diamond M.S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79:13350-13361.
57. Schneider B.S., McGee C.E., Jordan J.M., Stevenson H.L., Soong L., Higgs S. Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection. PLoS One 2007, 2:e1171.
58. Sciammas R., Bluestone J.A. TCRgammadelta cells and viruses. Microbes Infect. 1999, 1:203-212.
59. Sciammas R., Kodukula P., Tang Q., Hendricks R.L., Bluestone J.A. T cell receptor gammadelta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 1997, 185:1969-1975.
60. Selin L.K., Santolucito P.A., Pinto A.K., Szomolanyi-Tsuda E., Welsh R.M. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J. Immunol. 2001, 166:6784-6794.
61. Shahar A., Lustig S., Akov Y., David Y., Schneider P., Levin R. Different pathogenicity of encephalitic togaviruses in organotypic cultures of spinal cord slices. J. Neurosci. Res. 1990, 25:345-352.
62. Shen Y., Zhou D., Qiu L., Lai X., Simon M., Shen L., Kou Z., Wang Q., Jiang L., Estep J., Hunt R., Clagett M., Sehgal P.K., Li Y., Zeng X., Morita C.T., Brenner M.B., Letvin N.L., Chen Z.W. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 2002, 295:2255-2258.
63. Shrestha B., Gottlieb D., Diamond M.S. Infection and injury of neurons by West Nile encephalitis virus. J. Virol. 2003, 77:13203-13213.
64. Shrestha B., Wang T., Samuel M.A., Whitby K., Craft J., Fikrig E., Diamond M.S. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 2006, 80:5338-5348.
65. Sitati E.M., Diamond M.S. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 2006, 80:12060-12069.
66. Town T., Bai F., Wang T., Kaplan A.T., Qian F., Montgomery R.R., Anderson J.F., Flavell R.A., Fikrig E. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 2009, 30:242-253.
67. Tseng C.T., Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 2002, 195:43-49.
68. Wang L., Kamath A., Das H., Li L., Bukowski J.F. Antibacterial effect of human V gamma 2V delta 2 T cells in vivo. J. Clin. Invest. 2001, 108:1349-1357.
69. Wang T., Scully E., Yin Z., Kim J.H., Wang S., Yan J., Mamula M., Anderson J.F., Craft J., Fikrig E. IFN-gamma-producing gammadelta T cells help control murine West Nile virus infection. J. Immunol. 2003, 171:2524-2531.
70. Wang Y., Lobigs M., Lee E., Mullbacher A. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 2003, 77:13323-13334.
71. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10:1366-1373.
72. Wang T., Gao Y., Scully E., Davis C.T., Anderson J.F., Welte T., Ledizet M., Koski R., Madri J.A., Barrett A., Yin Z., Craft J., Fikrig E. Gammadelta T cells facilitate adaptive immunity against West Nile virus infection in mice. J. Immunol. 2006, 177:1825-1832.
73. Wang S., Welte T., McGargill M., Town T., Thompson J., Anderson J.F., Flavell R.A., Fikrig E., Hedrick S.M., Wang T. Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J. Immunol. 2008, 181:2084-2091.
74. Wang S., Welte T., Fang H., Chang G.J., Born W.K., O'Brien R.L., Sun B., Fujii H., Kosuna K., Wang T. Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. J. Nutr. 2009, 139:598-602.
75. Welte T., Lamb J., Anderson J.F., Born W.K., O'Brien R.L., Wang T. Role of two distinct gammadelta T cell subsets during West Nile virus infection. FEMS Immunol. Med. Microbiol. 2008, 53:275-283.
76. Welte, T., Aronson, J., Gong, B., Rachamallu, A., Mendell, N., Tesh, R., Paessler, S., Born, W., O'Brien, R., Wang, T., 2011. Vγ4+ T Cells Regulate Host Immune Response to West Nile Virus Infection FEMS Immunol Med Microbiol. 63, 183-192.
77. Xiao S.Y., Guzman H., Zhang H., Travassos da Rosa A.P., Tesh R.B. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg. Infect. Dis. 2001, 7:714-721.